Multiplikator Forward P/S: Orchestra BioMed, Inc. (OBIO)
The projected P/S trend reflects market expectations, where 12.20 represents the latest metric reading for Orchestra BioMed (OBIO). The production of cardiac systems remains stable following the implementation of laser automation. Physicians value the brand for its safe methods of targeted drug delivery into blood vessels. Revenues are based on B2B contracts with industry leaders in the treatment of cardiac pathologies.
Ringkesan rincian data analitis orchestrabiomed.com (OBIO)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Orchestra BioMed|OBIO - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Orchestra BioMed, Inc.|OBIO - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Orchestra BioMed, Inc.|OBIO - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Orchestra BioMed|Rasio cepet orchestrabiomed.com
- rincian asil keuangan lan kelipatan valuasi:
OBIO - Penghasilan resik perusahaan|Bathi sing dikarepake Orchestra BioMed|OBIO - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Orchestra BioMed|OBIO - Pangali PEG|Pangali EV/EBITDA Orchestra BioMed, Inc.|OBIO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Orchestra BioMed|OBIO - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan orchestrabiomed.com|OBIO - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Orchestra BioMed
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:OBIO (Orchestra BioMed)
Forward P/S assesses the market value of a business relative to expected revenue, allowing an investor to determine the extent of the premium paid for future growth rates. The current projected P/S value of 12.20 reflects market expectations for Orchestra BioMed (OBIO), where the efficiency of implementing sustainable production standards for cardiac devices directly impacts the company's future margins and investment attractiveness.
Karo sapa Orchestra BioMed saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan Axogen (AXGN)|SI-BONE Inc (SIBN) - Prakiraan rega marang pendapatan|Orthofix International - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bioventus Global BVS|OrthoPediatrics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake treace.com TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CARL (Carlsmed, Inc.)|Rasio rega marang prakiraan pendapatan RxSight Corp|Multiplikator forward rega marang pendapatan ClearPoint (CLPT)|Multiplikator Forward P/S STXS|STIM - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Sight Sciences SGHT|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|vivani.com (VANI) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Xtant Medical (XTNT)|Rasio rega marang prakiraan pendapatan NeuroOne Medical Technologies Corporation|MODD: Rega forward marang dodolan|Multiplikator Forward P/S MYO|Multiplikator forward rega marang pendapatan Envoy Medical Inc COCH|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|Rega forward marang dodolan NVNO|SINTX Technologies - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Rasio rega marang prakiraan pendapatan|AMIX - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan IVF|BBLG (bonebiologics.com) - Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Axonics (AXNX)|BIOL (BIOLASE Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S DYNT (Dynatronics)|Multiplikator Forward P/S Paragon 28 Inc. FNA|INVO: Multiplikator forward rega marang pendapatan
